Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164050296> ?p ?o ?g. }
- W2164050296 abstract "Identification of predictive markers of response to treatment is a major objective in breast cancer. A major problem in clinical sampling is the variability of RNA templates, requiring accurate management of tumour material and subsequent analyses for future translation in clinical practice. Our aim was to establish the feasibility and reliability of high throughput RNA analysis in a prospective trial. This study was conducted on RNA from initial biopsies, in a prospective trial of neoadjuvant chemotherapy in 327 patients with inoperable breast cancer. Four independent centres included patients and samples. Human U133 GeneChips plus 2.0 arrays for transcriptome analysis and quantitative RT-qPCR of 45 target genes and 6 reference genes were analysed on total RNA. Thirty seven samples were excluded because i) they contained less than 30% malignant cells, or ii) they provided RNA Integrity Number (RIN) of poor quality. Among the 290 remaining cases, taking into account strict quality control criteria initially defined to ensure good quality of sampling, 78% and 82% samples were eligible for transcriptome and RT-qPCR analyses, respectively. For RT-qPCR, efficiency was corrected by using standard curves for each gene and each plate. It was greater than 90% for all genes. Clustering analysis highlighted relevant breast cancer phenotypes for both techniques (ER+, PR+, HER2+, triple negative). Interestingly, clustering on trancriptome data also demonstrated a centre effect, probably due to the sampling or extraction methods used in on of the centres. Conversely, the calibration of RT-qPCR analysis led to the centre effect withdrawing, allowing multicentre analysis of gene transcripts with high accuracy. Our data showed that strict quality criteria for RNA integrity assessment and well calibrated and standardized RT-qPCR allows multicentre analysis of genes transcripts with high accuracy in the clinical context. More stringent criteria are needed for transcriptome analysis for clinical applications." @default.
- W2164050296 created "2016-06-24" @default.
- W2164050296 creator A5005453126 @default.
- W2164050296 creator A5012603842 @default.
- W2164050296 creator A5025546051 @default.
- W2164050296 creator A5026604806 @default.
- W2164050296 creator A5030928151 @default.
- W2164050296 creator A5047327833 @default.
- W2164050296 creator A5050645397 @default.
- W2164050296 creator A5053881729 @default.
- W2164050296 creator A5055130123 @default.
- W2164050296 creator A5059694416 @default.
- W2164050296 creator A5060740755 @default.
- W2164050296 creator A5063935599 @default.
- W2164050296 creator A5066239130 @default.
- W2164050296 creator A5075227088 @default.
- W2164050296 creator A5090178944 @default.
- W2164050296 creator A5091592799 @default.
- W2164050296 date "2011-06-01" @default.
- W2164050296 modified "2023-10-15" @default.
- W2164050296 title "Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients" @default.
- W2164050296 cites W1696199194 @default.
- W2164050296 cites W1965433248 @default.
- W2164050296 cites W1973614663 @default.
- W2164050296 cites W2010637767 @default.
- W2164050296 cites W2010871781 @default.
- W2164050296 cites W2014203284 @default.
- W2164050296 cites W2017559665 @default.
- W2164050296 cites W2023906705 @default.
- W2164050296 cites W2029787946 @default.
- W2164050296 cites W2030582688 @default.
- W2164050296 cites W2034729689 @default.
- W2164050296 cites W2048658106 @default.
- W2164050296 cites W2048771192 @default.
- W2164050296 cites W2078647713 @default.
- W2164050296 cites W2096976625 @default.
- W2164050296 cites W2097255042 @default.
- W2164050296 cites W2104607843 @default.
- W2164050296 cites W2105319066 @default.
- W2164050296 cites W2107665951 @default.
- W2164050296 cites W2109010167 @default.
- W2164050296 cites W2118126404 @default.
- W2164050296 cites W2120236927 @default.
- W2164050296 cites W2131915049 @default.
- W2164050296 cites W2139510434 @default.
- W2164050296 cites W2145526497 @default.
- W2164050296 cites W2148063507 @default.
- W2164050296 cites W2154273881 @default.
- W2164050296 cites W2162713066 @default.
- W2164050296 cites W2322310628 @default.
- W2164050296 cites W4294413353 @default.
- W2164050296 doi "https://doi.org/10.1186/1471-2407-11-215" @default.
- W2164050296 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3126791" @default.
- W2164050296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21631949" @default.
- W2164050296 hasPublicationYear "2011" @default.
- W2164050296 type Work @default.
- W2164050296 sameAs 2164050296 @default.
- W2164050296 citedByCount "30" @default.
- W2164050296 countsByYear W21640502962012 @default.
- W2164050296 countsByYear W21640502962013 @default.
- W2164050296 countsByYear W21640502962014 @default.
- W2164050296 countsByYear W21640502962015 @default.
- W2164050296 countsByYear W21640502962016 @default.
- W2164050296 countsByYear W21640502962017 @default.
- W2164050296 countsByYear W21640502962018 @default.
- W2164050296 countsByYear W21640502962019 @default.
- W2164050296 countsByYear W21640502962020 @default.
- W2164050296 countsByYear W21640502962021 @default.
- W2164050296 countsByYear W21640502962022 @default.
- W2164050296 crossrefType "journal-article" @default.
- W2164050296 hasAuthorship W2164050296A5005453126 @default.
- W2164050296 hasAuthorship W2164050296A5012603842 @default.
- W2164050296 hasAuthorship W2164050296A5025546051 @default.
- W2164050296 hasAuthorship W2164050296A5026604806 @default.
- W2164050296 hasAuthorship W2164050296A5030928151 @default.
- W2164050296 hasAuthorship W2164050296A5047327833 @default.
- W2164050296 hasAuthorship W2164050296A5050645397 @default.
- W2164050296 hasAuthorship W2164050296A5053881729 @default.
- W2164050296 hasAuthorship W2164050296A5055130123 @default.
- W2164050296 hasAuthorship W2164050296A5059694416 @default.
- W2164050296 hasAuthorship W2164050296A5060740755 @default.
- W2164050296 hasAuthorship W2164050296A5063935599 @default.
- W2164050296 hasAuthorship W2164050296A5066239130 @default.
- W2164050296 hasAuthorship W2164050296A5075227088 @default.
- W2164050296 hasAuthorship W2164050296A5090178944 @default.
- W2164050296 hasAuthorship W2164050296A5091592799 @default.
- W2164050296 hasBestOaLocation W21640502961 @default.
- W2164050296 hasConcept C104317684 @default.
- W2164050296 hasConcept C106131492 @default.
- W2164050296 hasConcept C112190416 @default.
- W2164050296 hasConcept C121608353 @default.
- W2164050296 hasConcept C126322002 @default.
- W2164050296 hasConcept C140779682 @default.
- W2164050296 hasConcept C143998085 @default.
- W2164050296 hasConcept C150194340 @default.
- W2164050296 hasConcept C151730666 @default.
- W2164050296 hasConcept C162317418 @default.
- W2164050296 hasConcept C188816634 @default.
- W2164050296 hasConcept C2778292576 @default.
- W2164050296 hasConcept C2779343474 @default.